Amyotrophic Lateral Sclerosis (ALS)

Speeding the Course of Clinical Trials

Speeding the Course of Clinical Trials

Speeding the course of clinical trials for Duchenne muscular dystrophy (DMD) and ALS (amyotrophic lateral sclerosis) is one of the main goals of MDA’s new clinical trial network – and the work already has begun.

In DMD ...

Investigators at five elite U.S. centers are working together to support trials and studies and collaborate on DMD-related projects. The centers are located at:

Origin of Viral Protein In ALS Elusive

A study in the May 29 issue of Neurology is the third to find that a viral protein known as reverse transcriptase is more frequently found in the blood of people with amyotrophic lateral sclerosis (ALS) than in those who don't have the disease.

Reverse transcriptase is an enzyme that retroviruses (a viral family that includes HIV) use to replicate themselves.